Loading your page…
Esparsentan
The same active substances on other registers, the same brand first.
This national listing belongs to a medicine the European Commission authorised for the whole EU.
| Pack | Code | Status |
|---|---|---|
| FILSPARI 400 MG COMPRIMIDOS RECUBIERTOS CON PELICULA, 30 comprimidos | 765774 |
The official texts, at the regulator.
Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.
Compiled by Prognia from the public register below; the register’s text is the official one.
Fuente de la información: Agencia Española de Medicamentos y Productos Sanitarios www.aemps.gob.es; CIMA medicamentos, acquired 11 October 2026 UTC; each source response/update date retained.
Licence: AEMPS explicit public open-data reuse for citizens and companies; source attribution and update date required · Added 12 Oct 2026
Report an error or request removalCorrections from the holder or the register are welcome.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.
